Xeris Biopharma Holdings, Inc. Share Price
XERSXeris Biopharma Holdings, Inc. Stock Performance
Open $6.98 | Prev. Close $7.04 | Circuit Range N/A |
Day Range $6.93 - $7.07 | Year Range $3.44 - $10.07 | Volume 37,462 |
Average Traded $7.01 |
Xeris Biopharma Holdings, Inc. Share Price Chart
About Xeris Biopharma Holdings, Inc.
Xeris Biopharma Holdings, Inc., a commercial-stage biopharmaceutical company, engages in developing and commercializing therapies for chronic endocrine and neurological diseases in Illinois. The company offers Gvoke, a ready-to-use liquid-stable glucagon for the treatment of severe hypoglycemia in pediatric and adult patients; Keveyis, a therapy for the treatment of hyperkalemic, hypokalemic, and related variants of primary periodic paralysis; and Recorlev, a cortisol synthesis inhibitor for the treatment of endogenous hypercortisolemia in adult patients with Cushing's syndrome. It is also developing XP-8121, a once-weekly subcutaneous injection of levothyroxine that is in phase 3 clinical trial for the treatment of hypothyroidism. The company was incorporated in 2005 and is headquartered in Chicago, Illinois.
Xeris Biopharma Holdings, Inc. Historical Data
| Day | Open | Close | Change % |
|---|---|---|---|
06-Feb-26 | $6.98 | $7.01 | +1.30% |
05-Feb-26 | $7.02 | $6.92 | -2.26% |
04-Feb-26 | $7.38 | $7.08 | -3.54% |
03-Feb-26 | $7.43 | $7.34 | -0.14% |
02-Feb-26 | $7.33 | $7.35 | -0.14% |
30-Jan-26 | $7.36 | $7.36 | +1.66% |
29-Jan-26 | $7.19 | $7.24 | +1.40% |